NewsRx

Search our medical news database

BTG

Agreement signed with the University of Illinois to develop sleep therapy

Published in Biotech Law Weekly, October 29th, 2004

BTG (BGC), the intellectual property and technology commercialization company, announced that it has signed a licensing and research agreement with the University of Illinois at Chicago (UIC) to further develop a novel pharmacological therapy for the treatment of sleep apnea.

BTG plans to invest in the development of this innovative therapy to expand its portfolio of therapeutic programs, particularly in the area of drug repositioning.

Under the terms of the agreement, UIC grants BTG specific exclusive rights to intellectual property and inventions related to the development of therapeutic treatment of sleep apnea, as well as rights to new...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook